Orchestrating inflammation: non-coding RNAs as master regulators of macrophage function in chronic obstructive

Xinyu Yong1,2, Xian Luo1,2, Xiaobing Chen1,2

  • 1Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.

Frontiers in Immunology
|November 13, 2025
PubMed

Insights

Non-coding RNAs (ncRNAs) critically regulate macrophage function in chronic obstructive pulmonary disease (COPD). Targeting these ncRNA-macrophage interactions offers promising avenues for personalized COPD diagnostics and therapies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pulmonary Medicine

Background:

  • Chronic obstructive pulmonary disease (COPD) is a significant global health issue.
  • Macrophage dysfunction and chronic inflammation are hallmarks of COPD.
  • Non-coding RNAs (ncRNAs) are increasingly recognized for their role in regulating macrophage behavior.

Purpose of the Study:

  • To review the current evidence on how ncRNA-macrophage regulatory axes contribute to COPD pathogenesis.
  • To explore the diagnostic and therapeutic potential of ncRNAs in COPD.
  • To identify challenges and future directions in ncRNA-based COPD research.

Main Methods:

  • Comprehensive literature review of studies investigating ncRNAs (miRNAs, lncRNAs, circRNAs) and their impact on macrophage polarization in COPD.
  • Analysis of molecular pathways (e.g., NF-κB, STAT3) involved in ncRNA-mediated inflammation.
  • Examination of clinical studies translating mechanistic insights into biomarkers and therapeutic targets.

Main Results:

  • Pro-inflammatory miRNAs (e.g., miR-155) drive M1 macrophage polarization and inflammation.
  • Anti-inflammatory miRNAs promote resolution of inflammation.
  • Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) employ complex regulatory mechanisms, including acting as scaffolds and competing for microRNAs.
  • ncRNAs have shown potential as diagnostic biomarkers and therapeutic targets in human COPD patients.

Conclusions:

  • ncRNA-macrophage regulatory axes are key drivers of COPD progression.
  • Targeting these axes presents a promising strategy for developing novel diagnostics and therapeutics for COPD.
  • Further research is needed to overcome methodological challenges and fully realize the clinical potential of ncRNA-based precision medicine in COPD management.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Master Transcription Regulators02:23

Master Transcription Regulators

2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
514